These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 36333719)

  • 21. N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma.
    Ming J; Wang C
    Front Genet; 2022; 13():871899. PubMed ID: 35495133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma.
    Yao N; Zuo L; Yan X; Qian J; Sun J; Xu H; Zheng F; Efird JT; Kawagoe I; Wang Y; Ni S
    Transl Lung Cancer Res; 2022 Apr; 11(4):632-646. PubMed ID: 35529787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma.
    Yang Q; Gong H; Liu J; Ye M; Zou W; Li H
    Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer.
    Huang Z; Lou K; Liu H
    Front Genet; 2022; 13():1030275. PubMed ID: 36313442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a disulfidptosis-related lncRNA prognostic signature for enhanced prognostic assessment and therapeutic strategies in lung squamous cell carcinoma.
    Zhu A; Zong Y; Gao X
    Sci Rep; 2024 Aug; 14(1):17804. PubMed ID: 39090162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
    Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M
    Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z; Wang J; Han W; Zhao L
    BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma.
    Luo P; Jiang Y; Ding S; Jiang S; Tang R; Tang Z
    Biomed Res Int; 2022; 2022():4944758. PubMed ID: 35692583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.
    Weng C; Wang L; Liu G; Guan M; Lu L
    Front Oncol; 2021; 11():763027. PubMed ID: 34868980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
    Tian WJ; Liu SS; Li BR
    Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma.
    Zhou Y; Wang L; Zhang W; Ma J; Zhang Z; Yang M; Yu J; Luo J; Yan Z
    Dis Markers; 2022; 2022():6335155. PubMed ID: 35111268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of pyroptosis-related long non-coding RNAs with prognosis and therapy in lung squamous cell carcinoma.
    Zhang Y; Wang Y; Yin X; Huang Y
    Sci Rep; 2022 Jul; 12(1):11206. PubMed ID: 35778526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma.
    Huang H; Wu W; Lu Y; Pan X
    J Thorac Dis; 2022 Oct; 14(10):4055-4072. PubMed ID: 36389308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
    Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
    Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma.
    Ji L; Liang S; Cheng Y; Gao R; Yan W; Pang F; Zhang F
    Cancer Biomark; 2024; 40(3-4):319-342. PubMed ID: 39213052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.